20/20 Biolabs, Inc. (AIDX)
0.8669
-0.08
(-8.75%)
USD |
NASDAQ |
May 29, 16:00
0.879
+0.01
(+1.40%)
After-Hours: 20:00
20/20 Biolabs Shareholders Equity (Quarterly) : 2.757M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sanara MedTech, Inc. | 7.028M |
| Intelligent Bio Solutions, Inc. | 8.962M |
| Anteris Technologies Global Corp. | 278.44M |
| FONAR Corp. | 178.57M |
| Quest Diagnostics, Inc. | 7.366B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.803M |
| Total Liabilities (Quarterly) | 3.046M |
| Debt to Equity Ratio | 0.3357 |
| Current Ratio | 1.822 |
| Net Debt Paydown Yield | 0.40% |